Combination of renal angioplasty and angiotensin-converting-enzyme inhibitor can reduce proteinuria in patients with bilateral renal artery disease

Research output: Contribution to journalArticle

Abstract

Recent large clinical trials failed to show clear benefits of percutaneous transluminal renal angioplasty (PTRA) as compared with medical therapy on patients with renal artery stenosis. It was also reported that proteinuria is an adverse prognostic factor after PTRA, and PTRA is less effective in patients with overt proteinuria. From the renoprotective point of view, to reduce proteinuria after PTRA is an important therapeutic goal in patients with renal artery stenosis with overt proteinuria. We hereby describe two patients successfully treated by combination therapy with PTRA and administration of angiotensin-converting enzyme (ACE) inhibitor for bilateral renal artery disease with overt proteinuria.

Original languageEnglish
Pages (from-to)1917-1922
Number of pages6
JournalInternal Medicine
Volume58
Issue number13
DOIs
Publication statusPublished - 2019

Keywords

  • Angioplasty
  • Angiotensin-converting-enzyme inhibitor
  • Proteinuria
  • Renal artery disease

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Combination of renal angioplasty and angiotensin-converting-enzyme inhibitor can reduce proteinuria in patients with bilateral renal artery disease'. Together they form a unique fingerprint.

  • Cite this